Percutaneous Transluminal Angioplasty Balloons Market: By Product Type, By Application, By End Users, By Route of Administration, and Geography
Percutaneous Transluminal Angioplasty (PTA) Balloons Market is poised to grow at a CAGR of 4% from 2024-2030. Percutaneous transluminal angioplasty (PTA) is a process carried to treat the peripheral artery disease (PAD) by open up the arteries that are narrowed by plaque. Percutaneous transluminal angioplasty (PTA) is a procedure in which a small flexible catheter with a diameter of only a few millimetres is introduced into an artery and guided to a desired site where the blood vessel has narrowed due to cardiovascular disease. A tiny balloon is inflated at the end of the catheter when it reaches the target place, squeezing the blocking component responsible for the restricted artery against the blood vessel wall and restoring normal blood flow. When the balloon is inflated, the blood vessel opening widens, allowing more blood to flow to the heart. During the procedure, a stent is frequently used to maintain the artery open after the balloon is deflated and removed.
Superior technological advancements such as progressive flexibility due to innovations in hydrophilic design, superior hydrophilic coatings, improved performance under high pressure due to added pushability, and robust design reducing friction are expected to drive the global percutaneous transluminal angioplasty balloons market growth during the forecast period. Rising reimbursement coverage for the treatment of cardiac diseases, especially among end-users in developing countries (which have a relatively higher patient population), are some of the factors likely to drive the growth of the global percutaneous transluminal angioplasty balloons market between 2017 and 2025. However, the risk of patient discomfort during balloon inflation and the possibility of restenosis are two factors that are anticipated to limit the worldwide Percutaneous Transluminal Angioplasty (PTA) Balloons Market growth over the forecast period.
Study Period
2024-2030Base Year
2023CAGR
4%Largest Market
North AmericaFastest Growing Market
Europe
Increase in the prevalence of peripheral or coronary artery diseases, development in imaging technologies, recent launch of several percutaneous transluminal angioplasty balloons, and rise in R&D for the manufacturing of advanced technology balloons such as drug-eluting balloons are anticipated to fuel the percutanleous transluminal angioplasty balloons market over the forecast period. However, stringent guidelines for product approval, high cost of PTA balloons, and lack of awareness about advanced PTA balloons in underdeveloped countries may restrain the growth of percutaneous transluminal angioplasty balloons market.
Geographically, global percutaneous transluminal angioplasty (PTA) balloons market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa regions. North America percutaneous transluminal angioplasty balloons market growth driven by rise in prevalence of peripheral and coronary artery diseases, rise in R&D for the innovation of advanced products, and sophisticated healthcare infrastructure in the region. Europe percutaneous transluminal angioplasty balloons market accounted for significant share due to rise in R&D activities by the Europe companies, high adoption of advanced PTA balloons by healthcare professionals, and increase in healthcare expenditure. Asia Pacific percutaneous transluminal angioplasty balloons market is poised to grow at significant rate due to rise in prevalence of coronary and peripheral artery diseases, increase in geriatric population and prevalence of diabetes, rise in medical tourism in Asia Pacific countries are anticipated to propel the market. Latin America percutaneous transluminal angioplasty balloons market has a lucrative growth, which is attributed to expansion of the businesses by the market players, rise in prevalence of artery diseases, and conomic growth. Middle East and Africa percutaneous transluminal angioplasty balloons market expected to present better growth opportunity for market players owing to rise in awareness about PTA balloons in South Africa, and rise in prevalence of artery diseases in Middle East region.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market CAGR |
4% |
|
By Product Type |
|
|
By Application |
|
|
By End User |
|
|
By Route of Administration |
|
Download Free Sample Report
The Percutaneous Transluminal Angioplasty (PTA) Balloons Market is poised to grow at a CAGR of 4% during the forecast period 2024-2030.
The Percutaneous Transluminal Angioplasty (PTA) Balloons Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
Europe is the fastest-growing for Percutaneous Transluminal Angioplasty (PTA) Balloons Market
| 1.Executive Summary |
| 2.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market Introduction |
| 2.1.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market - Taxonomy |
| 2.2.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Application |
| 2.2.3.End User |
| 2.2.4.Route of Administration |
| 2.2.5.Region |
| 3.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market Analysis, 2019-2023 and Forecast 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market By Product Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 5.1. Drug-Eluting Balloons |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Normal Balloons |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Scoring Balloons |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Cutting Balloons |
| 5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market By Application, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 6.1. Peripheral Artery Disease |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Coronary Artery Disease |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market By End User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Cardiology Clinics |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Ambulatory Surgical Centers |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market By Route of Administration, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 8.1. Injection |
| 8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Nasal Spray |
| 8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 9.Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Percutaneous Transluminal Angioplasty (PTA) Balloons Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Drug-Eluting Balloons |
| 10.1.2.Normal Balloons |
| 10.1.3.Scoring Balloons |
| 10.1.4.Cutting Balloons |
| 10.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Peripheral Artery Disease |
| 10.2.2.Coronary Artery Disease |
| 10.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Cardiology Clinics |
| 10.3.3.Ambulatory Surgical Centers |
| 10.4. Route of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Injection |
| 10.4.2.Nasal Spray |
| 10.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Percutaneous Transluminal Angioplasty (PTA) Balloons Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Drug-Eluting Balloons |
| 11.1.2.Normal Balloons |
| 11.1.3.Scoring Balloons |
| 11.1.4.Cutting Balloons |
| 11.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Peripheral Artery Disease |
| 11.2.2.Coronary Artery Disease |
| 11.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Cardiology Clinics |
| 11.3.3.Ambulatory Surgical Centers |
| 11.4. Route of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Injection |
| 11.4.2.Nasal Spray |
| 11.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12.Asia Pacific (APAC) Percutaneous Transluminal Angioplasty (PTA) Balloons Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Drug-Eluting Balloons |
| 12.1.2.Normal Balloons |
| 12.1.3.Scoring Balloons |
| 12.1.4.Cutting Balloons |
| 12.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Peripheral Artery Disease |
| 12.2.2.Coronary Artery Disease |
| 12.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Cardiology Clinics |
| 12.3.3.Ambulatory Surgical Centers |
| 12.4. Route of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Injection |
| 12.4.2.Nasal Spray |
| 12.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Percutaneous Transluminal Angioplasty (PTA) Balloons Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Drug-Eluting Balloons |
| 13.1.2.Normal Balloons |
| 13.1.3.Scoring Balloons |
| 13.1.4.Cutting Balloons |
| 13.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Peripheral Artery Disease |
| 13.2.2.Coronary Artery Disease |
| 13.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Cardiology Clinics |
| 13.3.3.Ambulatory Surgical Centers |
| 13.4. Route of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Injection |
| 13.4.2.Nasal Spray |
| 13.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Percutaneous Transluminal Angioplasty (PTA) Balloons Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Drug-Eluting Balloons |
| 14.1.2.Normal Balloons |
| 14.1.3.Scoring Balloons |
| 14.1.4.Cutting Balloons |
| 14.2. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Peripheral Artery Disease |
| 14.2.2.Coronary Artery Disease |
| 14.3. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Hospitals |
| 14.3.2.Cardiology Clinics |
| 14.3.3.Ambulatory Surgical Centers |
| 14.4. Route of Administration Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Injection |
| 14.4.2.Nasal Spray |
| 14.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.R. Bard, Inc. (U.S.) |
| 15.2.2.Cook Medical, Inc. (U.S.) |
| 15.2.3.Abbott, Inc. (U.S.) |
| 15.2.4.Cardinal Health, Inc. (U.S.) |
| 15.2.5.Boston Scientific Corporation (U.S.) |
| 15.2.6.Spectranetics Corporation (Philips Holding USA Inc.) (U.S.) |
| 15.2.7.Medtronic Plc (Ireland) |
| 15.2.8.SurModics Inc. (U.S.) |
| 15.2.9.ENDOCOR GmbH (Germany) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
